Antibiotic resistance patterns in ICU patients
Part of Infections clinical trials.
This study looks at how bacteria in the lungs become resistant to antibiotics. It may help doctors choose better treatments for people with serious lung infections in the intensive care unit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in the respiratory ICU with a lung infection.
- You have been treated with antibiotics.
- A sample of sputum or fluid from your lungs has been collected for testing.
- You are not HIV positive.
- You must survive at least 48 hours after being admitted.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how antibiotics (“anti-microbial” medicines) are being used in the pediatric intensive care unit (PICU). It mainly includes children who stay in the ICU for more than 48 hours, to better understand and improve safe antibiotic practices.
This study looks at certain drug-resistant bacteria in the gut of ICU patients. It aims to understand how common these bacteria are and may help guide future infection control efforts.
This study observes how bacteria in the lungs of people with chronic lung diseases like bronchiectasis or COPD develop resistance to antibiotics. By tracking your lung health and bacterial samples over time, researchers hope to better understand and prevent antibiotic resistance.
This study looks at treating ICU patients with sepsis (a serious body-wide infection) using antibiotics. It may help doctors understand which antibiotic approach works best for critically ill patients.
This study follows people who are admitted to a respiratory intensive care unit (a special ICU for breathing problems) because they have pneumonia. It may help doctors better understand pneumonia in ICU patients and improve care in the future.
This study looks at how having a weakened immune system affects the risk of getting infections with hard-to-treat bacteria in the ICU. Depending on your immune status, you may be placed in a group that helps doctors understand who is most at risk.
Hear when a new Antibiotics Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.